NASDAQ$HSIC

Henry Schein Inc · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Briefing

Henry Schein reported Q4 2025 net sales of $3.19B and GAAP EPS of $0.85.

Q4 net sales rose 7.7% to $3.19 billion—the highest sales growth in 15 quarters. GAAP net income $101 million ($0.85 EPS); non-GAAP EPS $1.34. Equipment, specialty, and technology led growth. 2026 non-GAAP EPS guide $5.23–$5.37; sales growth 3%–5%.

  • Q4 sales $3.19B (+7.7%).
  • GAAP EPS $0.85; non-GAAP $1.34.
  • BOLD+1 strategy driving H2 momentum.
  • 2026 non-GAAP EPS $5.23–$5.37.

Headline financials

Total Revenue

$3.44B

Previous: $3.19B+7.7%
EPS (adj)

$1.34

Previous: $1.19+12.6%
Adjusted EBITDA

$291M

Previous: $270M+7.8%
Shares Repurchased

2.8M

No prior period
Total Repurchase Cost

$200M

No prior period
Internal Sales Growth

4.9%

No prior period
Capital Expenditures

-$43M

Previous: -$36M-19.4%
Net Income

$103M

Previous: $94M+9.6%
Operating Income

$163M

Previous: $155M+5.2%
Gross Profit

$1.06B

Previous: $993M+7.0%

Revenue & EPS history

Henry Schein · Revenue · Quarterly

$3.44B

Q4 2025+7.7%vs Q4 2024
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

Henry Schein · $3B total across 2 segments · Q3 2023

  • Global Dental
    $1.9B+5.6%
  • Global Medical
    $1.1B+0.0%

Forward guidance

FY 2026 non-GAAP diluted EPS $5.23–$5.37 with 3%–5% sales growth under BOLD+1 plan.

Tailwinds

  • Dental and medical equipment strength.
  • Cloud software adoption accelerating.
  • Highest quarterly sales growth in 15 quarters.

Headwinds

  • Restructuring and integration costs ongoing.
  • FX on international dental.
  • Competitive pricing in distribution.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-0.4%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-0.6%

Avg return

30 days after

45%

31 / 69 earnings

Positive

+11.1%

Q4 2021

Best reaction

-8.5%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.3%-1.6%+4.6%
Q4 2025+5.8%+2.3%-8.5%
Q3 2025+10.9%+11.2%+13.5%
Q1 2025+2.0%+5.1%+7.8%
Q4 2024-2.3%-7.0%-10.6%
Q3 2024-3.2%-6.0%+0.2%
Q2 2024-5.4%-0.9%+0.4%
Q1 2024+6.2%+7.0%+0.1%
Q4 2023-5.1%-4.6%-6.3%
Q3 2023+7.5%+7.3%+15.5%
Q2 2023-2.8%-1.8%-5.1%
Q1 2023-4.5%-4.2%-6.1%
Q4 2022-6.2%-7.5%-12.8%
Q3 2022+1.8%+6.2%+21.2%
Q2 2022-4.9%-3.8%-7.3%
Q1 2022+7.4%+6.6%+5.6%
Q4 2021+11.1%+10.1%+14.5%
Q3 2021+3.0%+4.5%-6.7%
Q2 2021-4.8%-5.2%-2.3%
Q1 2021+6.6%+8.9%+5.3%
Q4 2020-8.5%-6.5%-5.3%
Q3 2020-5.0%-3.0%+4.6%
Q2 2020-5.3%-4.4%-6.9%
Q1 2020+0.4%+2.9%+20.6%
Q4 2019-8.4%-14.4%-38.9%
Q3 2019+4.4%+4.8%+5.2%
Q2 2019-3.2%-2.3%-4.2%
Q1 2019+8.6%+8.9%+8.6%
Q4 2018-5.0%-5.2%-5.2%
Q3 2018+3.1%+0.8%+3.3%
Q2 2018-0.5%-3.6%+0.5%
Q1 2018-6.1%-4.4%-6.7%
Q4 2017-1.2%-2.1%-5.2%
Q3 2017-8.5%-13.6%-13.0%
Q2 2017-7.7%-7.2%-4.9%
Q1 2017+0.6%+0.3%+5.2%
Q4 2016+2.7%+3.2%+2.0%
Q3 2016+4.6%+6.2%+1.7%
Q2 2016-7.1%-8.4%-8.6%
Q1 2016-2.5%
Q4 2015+7.0%
Q3 2015+1.1%
Q2 2015-1.9%
Q1 2015-0.4%
Q4 2014+0.9%
Q3 2014+5.4%
Q2 2014-1.8%
Q1 2014-1.7%
Q4 2013+0.1%
Q3 2013-2.6%
Q2 2013-0.3%
Q1 2013+2.1%
Q4 2012-2.2%
Q3 2012-0.6%
Q2 2012+1.8%
Q1 2012+2.4%
Q4 2011+3.4%
Q3 2011-6.4%
Q2 2011-2.3%
Q1 2010-2.0%
Q1 2011+0.5%
Q4 2010-3.9%
Q1 2009-3.9%
Q4 2008-3.9%
Q3 2009-4.1%
Q3 2010-4.1%
Q2 2010+2.1%
Q4 2009+2.1%
Q2 2009+2.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro